tirzepatide news today FDA says the weight-loss drug shortage is over F.D.A. Approves New Obesity Drug

How Retatrutide Works Retatrutide works by simultaneously activating three key hormonal pathways: GLP-1 Receptor Agonism: Enhances insulin secretion in response to elevated blood glucose levels, suppresses glucagon release, and slows gastric emptying

Appetite suppression comes on more gradually

This phenomenon reflects a complex interplay between sports psychology, the powerful placebo effect, and theoretical pharmacology

We find that -arrestin recruitment to GLP-1Rs during sustained agonist exposure has the opposite effect on insulin release to the known positive role of -arrestin-1 during acute GLP-1R stimulation in beta cells 14